切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2023, Vol. 16 ›› Issue (02) : 290 -292. doi: 10.3877/cma.j.issn.1674-6902.2023.02.039

综述

肺磨玻璃结节自然衍变规律与CT鉴别诊断研究现状及进展
熊廷伟1, 褚志刚1, 吕发金1,()   
  1. 1. 400016 重庆,重庆医科大学附属第一医院放射科
  • 收稿日期:2022-10-17 出版日期:2023-04-25
  • 通信作者: 吕发金
  • 基金资助:
    重庆市技术创新与应用发展专项重点项目(CSTC2021jscx-sbN0030); 重庆市科卫联合医学科研重点项目(2022ZDXM006)

Current status and progress in the study of natural evolution patterns and CT differential diagnosis of pulmonary ground glass nodules

Tingwei Xiong1, Zhigang Chu1, Fajin Lyu1()   

  • Received:2022-10-17 Published:2023-04-25
  • Corresponding author: Fajin Lyu
引用本文:

熊廷伟, 褚志刚, 吕发金. 肺磨玻璃结节自然衍变规律与CT鉴别诊断研究现状及进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 290-292.

Tingwei Xiong, Zhigang Chu, Fajin Lyu. Current status and progress in the study of natural evolution patterns and CT differential diagnosis of pulmonary ground glass nodules[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(02): 290-292.

肺磨玻璃结节(ground-glass nodule, GGN)定义为存在于肺内的局灶性密度增高影但不足以掩盖潜在的支气管及血管束的一类病变,按照GGN是否伴有实质成分,可分为纯磨玻璃结节(pure ground-glass nodule, pGGN)和部分实性结节(part-solid nodule, PSN)[1,2,3]。近年来,随着胸部低剂量CT(low-dose computed tomography, LDCT)的应用以及肺癌筛查普及率上升,GGN的检出率不断升高[4,5]。GGN性质多样,可以是非肿瘤性病变,也可是肿瘤性病变;病理上GGN表现为局灶纤维化、肺泡出血、炎症、肿瘤细胞贴壁式生长,而其内的实性成分常为肿瘤细胞浸润生长、肿瘤细胞堆积、间质纤维化、细胞塌陷所致。根据2021版WHO肺肿瘤分类[6],非典型腺瘤样增生(atypical adenomatous hyperplasia, AAH)和原位腺癌(adenocarcinoma in situ, AIS)归类为前驱腺体病变,微浸润腺癌(minimally invasive adenocarcinoma, MIA)和浸润性腺癌(invasive adenocarcinoma, IAC)归类为腺癌。AAH由非典型的Ⅱ型肺泡细胞或肺泡壁和呼吸细支气管细胞的增生形成;AIS一般没有间质或血管浸润,而当浸润范围<5 mm时称为MIA、当浸润范围>5 mm则为IAC[5,7]。GGN的生长衍变过程遵循由AAH、AIS、MIA到IAC的自然进展规律,GGN的生长衍变是一个动态过程,不会一直处于某个病理阶段,通过连续随访观察GGN的衍变模式了解GGN发展趋势较单一研究某一病理阶段的形态学改变的临床价值更大。本文对GGN的衍变模式进行综述,为肺GGN的个体化管理以及临床诊疗策略的制定提供参考依据。

1
Yu Y, Wang N, Huang N, et al. Determining the invasiveness of ground-glass nodules using a 3D multi-task network[J]. Eur Radiol, 2021, 31(9): 7162-7171.
2
陈 文,单 奔,陈小宇. 高分辨率CT下肺磨玻璃结节影像学特征以及术后病理比较[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(3): 288-292.
3
望 云,张正委,范 丽,等. 原发性结节肿块型肺黏液腺癌的CT表现与病理基础[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(2): 151-156.
4
Hammer MM, Palazzo LL, Eckel AL, et al. A decision analysis of follow-up and treatment algorithms for nonsolid pulmonary nodules[J]. Radiology, 2019, 290(2): 506-513.
5
Hammer MM, Hatabu H. Subsolid pulmonary nodules: Controversy and perspective[J]. Eur J Radiol Open, 2020, 100267.
6
李 袁,谢惠康,武春燕. WHO胸部肿瘤分类(第5版)中肺肿瘤部分解读[J]. 中国癌症杂志2021, 31(7): 574-580.
7
Pedersen JH, Saghir Z, Wille MM, et al. Ground-glass opacity lung nodules in the Era of lung cancer CT creening: Adiology,pathology, and clinical management[J]. Oncology (Williston Park), 2016, 30(3): 266-274.
8
杨智明,陈亚男,陈武飞,等. 肺磨玻璃结节形态学衍变模式研究进展[J]. 放射学实践2017, 32(12): 1309-1312.
9
Silva M, Prokop M, Jacobs C, et al. Long-term active surveillance of screening detected subsolid nodules is a safe strategy to reduce overtreatment[J]. J Thorac Oncol, 2018, 13(10): 1454-1463.
10
Lee HW, Jin KN, Lee JK, et al. Long-term follow-up of ground-glass nodules after 5 years of stability[J]. J Thorac Oncol, 2019, 14(8): 1370-1377.
11
Gao C, Li JY, Wu LY, et al. The natural growth of subsolid nodules predicted by quantitative initial CT features: A systematic review[J]. Front Oncol, 2020, 10: 318.
12
Lee HY, Choi YL, Lee KS, et al. Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management[J]. AJR, 2014, 202(3): W224-233.
13
Chu ZG, Li WJ, Fu BJ, et al. CT characteristics for predicting invasiveness in pulmonary pure ground-glass nodules[J]. AJR Am J Roentgenol, 2020, 215(2): 351-358.
14
Kakinuma R, Muramatsu Y, Kusumoto M, et al. Solitary pure ground-glass nodules 5 mm or smaller: Frequency of growth[J]. Radiology, 2015, 276(3): 873-882.
15
Kakinuma R, Noguchi M, Ashizawa K, et al. Natural history of pulmonary subsolid nodules: A prospective multicenter study[J]. J Thorac Oncol, 2016, 11(7): 1012-1028.
16
葛虓俊,高 丰,李 铭,等. 磨玻璃结节中实性成分对肺腺癌术前CT诊断的价值[J]. 中华医学杂志2014, 94(13): 1010-1013.
17
Li WJ, Lv FJ, Tan YW, et al. Benign and malignant pulmonary part-solid nodules: differentiation via thin-section computed tomography[J]. Quant Imaging Med Surg, 2022, 12(1): 699-710.
18
马伟玲,谭明瑜,赵 伟,等. 不同类型的晕征在肺混合磨玻璃结节CT诊断中的价值[J]. 临床放射学杂志2020, 39(6): 1099-1103.
19
Hsu WC, Huang PC, Pan KT, et al. Predictors of invasive adenocarcinomas among pure ground-glass nodules less than 2 cm in diameter[J]. Cancers, 2021, 13(16): 3945.
20
Qi LL, Wu BT, Tang Wei, et al. Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning-assisted nodule segmentation[J]. Eur Radiol, 2020, 30(2): 744-755.
21
Sang ML, Chang MP, Jin MG, et al. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features[J]. Radiology, 2013, 268(1): 265-273.
22
Jong HL, Chang MP, Sang ML, et al. Persistent pulmonary subsolid nodules with solid portions of 5 mm or smaller: Their natural course and predictors of interval growth[J]. Eur Radiol, 2016, 26(6): 1529-1537.
23
Lin Q, Ke X, Cheng L, et al. Analysis of CT morphologic features and attenuation for differentiating among transient lesions, atypical adenomatous hyperplasia, adenocarcinoma in situ, minimally invasive and invasive adenocarcinoma presenting as pure ground-glass nodules[J]. Sci Rep, 9(1): 14586.
24
Kobayashi Y, Mitsudomi T. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?[J]. Transl Lung Cancer Res, 2013, 2(5): 354-363.
25
Chang B, Hwang JH, Choi YH, et al. Natural history of pure ground-glass opacity lung nodules detected by low dose CT scan[J]. Chest, 2013, 143(1): 172-178.
26
Lee SW, Leem CS, Kim TJ, et al. The long-term course of ground-glass opacities detected on thin-section computed tomography[J]. Respir Med, 2013, 107(6): 904-910.
27
Oda S, Awai K, Murao K, et al. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided threedimensional volumetry[J]. Acad Radiol, 2011, 8(1): 63-69.
28
Yoon HY, Bae JY, Kim YY, et al. Risk factors associated with an increase in the size of ground-glass lung nodules on chest computed tomography[J]. Thorac Cancer, 2019, 10(7): 1544-1551.
29
Min JH, Lee HY, Lee KS, et al. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years[J]. Lung cancer, 2010, 69(1): 123-126.
30
高 丰,葛虓俊,李 铭,等. 经多层螺旋CT探讨肺磨玻璃结节与支气管的关系[J]. 中华放射学杂志2013, 47(2): 157-161.
31
袁焕初,郑晓林,邹玉坚,等. 肺局限性磨玻璃影与支气管关系的多层螺旋CT表现[J]. 分子影像学2017, 40(1): 12-15.
32
Gao F, Sun YL, Zhang GZ, et al. CT characterization of different pathological types of subcentimeter pulmonary ground-glass nodular lesions[J]. Br J Radiol, 2019, 92(1094): 20180204.
33
Li WJ, Lv FJ, Tan YW, et al. Pulmonary benign ground-glass nodules: CT features and pathological findings[J]. Int J Gen Med, 2021, 14: 581-590.
34
Fu BJ, Lv FJ, Li WJ, et al. Significance of intra-nodular vessel sign in differentiating benign and malignant pulmonary ground-glass nodules[J]. Insights Imaging, 2021, 12(1): 65.
35
Moon Y, Sung SW, Lee KY, et al. Pure ground-glass opacity on chest computed tomography:predictive factors for invasive adenocarcinoma[J]. J Thorac Dis, 2016, 8(7): 1561-1570.
[1] 陈经欣, 李梅, 陈洁雅. 肺结节胸腔镜术后肺部感染危险因素分析[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 238-243.
[2] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[3] 周杉京, 诸葛金科, 王芳芳. 补肺活血胶囊对COPD患者cCor、ALD、Ang-Ⅱ的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 517-519.
[4] 王庆, 张红联, 吴志勇. COPD合并多重耐药菌肺部感染预后危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 557-559.
[5] 葛卫卫, 李伟, 李荣兴, 成亚会, 李青松. MSCT与HRCT在不同病理类型肺磨玻璃结节中的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 572-574.
[6] 刘玲, 肖颖, 王蓉. 严重创伤并发肺部感染死亡病例分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 581-583.
[7] 郝昭昭, 李多, 南岩东. 以肺磨玻璃结节为表现的肺腺癌发生机制研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 435-437.
[8] 张晓娟, 邓祥瑞, 陈睿, 钟文. AECOPD伴肺部感染吸入三联疗效与EOS相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 364-366.
[9] 邢海东, 胡满意, 许贺松, 李强. CT纹理特征对肺磨玻璃结节生长倾向的预测意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 406-408.
[10] 谭烨, 徐盼, 唐喜军, 温赐祥, 于晓勇, 李静. micro RNA-26a与肺部超声评分对重度COPD撤机结局的预测[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 415-417.
[11] 梁华, 黄承军, 鄂桂香, 李静. 胸腺肽多索茶碱治疗COPD并发肺部感染的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 218-220.
[12] 叶晓芳, 杨京华, 武元星, 朱光发. COPD患者冠状动脉旁路移植术后肺部感染的预后影响及危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 175-179.
[13] 张沥, 宋俊华, 何皓, 杨雪瑶, 周康. 血清D-D、PAI-1、sICAM-1水平与糖尿病合并肺部感染病情严重程度及预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 203-205.
[14] 宋璇, 刘新艳, 杨大强, 杨茂鹏, 秦冰新, 田首成, 郭秀燕, 刘紫微, 王春亭. 肺超声弹性成像在肺部疾病中的应用进展[J]. 中华临床医师杂志(电子版), 2023, 17(02): 215-219.
[15] 强光峰, 孟兰兰, 赵静, 牛峰海, 任雪云. 肺部超声评分对呼吸困难新生儿使用有创机械通气的预测价值[J]. 中华诊断学电子杂志, 2023, 11(02): 104-108.
阅读次数
全文


摘要